Structures by: Smit J. P.
Total: 8
Nifedipine--pyrazine (2/1)
C17H18N2O6,0.5(C4H4N2)
Acta Crystallographica Section E (2010) 66, 9 o2297-o2298
a=13.6278(14)Å b=9.1594(9)Å c=14.4432(14)Å
α=90.00° β=94.841(4)° γ=90.00°
214544 (3709-57-04)
C9H8O3,C6H6N2O
Crystal Growth & Design (2014) 14, 3 1438
a=15.5106(10)Å b=6.2871(4)Å c=14.1238(10)Å
α=90.00° β=106.086(3)° γ=90.00°
212394 (3709-54-05)
C9H8O3,C6H6N2O
Crystal Growth & Design (2014) 14, 3 1438
a=40.076(2)Å b=7.1979(4)Å c=22.2876(12)Å
α=90.00° β=122.479(2)° γ=90.00°
B4CuLi6O10
B4CuLi6O10
Journal of the American Chemical Society (2006) 128, 35 11631-11634
a=4.8131(6)Å b=6.4288(8)Å c=7.0223(9)Å
α=83.369(2)° β=71.623(2)° γ=73.364(2)°
B4Cu3O11Pb2
B4Cu3O11Pb2
Inorganic Chemistry (2007) 46, 3851-3855
a=6.8016(15)Å b=4.7123(10)Å c=14.614(3)Å
α=90.00° β=97.089(3)° γ=90.00°
B2BaO4
B2BaO4
Crystal Growth & Design (2007) 7, 8 1561
a=8.3824(3)Å b=8.3824(3)Å c=8.3824(3)Å
α=96.86° β=96.86° γ=96.86°
?
C44H70O23,4(H2O1),C1H4O1
Crystal Growth & Design (2012) 12, 2 990
a=16.4358(9)Å b=8.0564(4)Å c=19.5073(11)Å
α=90.00° β=100.120(4)° γ=90.00°
Li6Mo12O39
Li6Mo12O39
Crystal Growth & Design (2007) 7, 3 521
a=8.2178(5)Å b=21.2814(13)Å c=8.5950(5)Å
α=90.00° β=96.0880(10)° γ=90.00°